All stock lists
Solventum Corp (SOLV)
NYSE: SOLV · Real-Time Price · USD
Healthcare · Medical Instruments & Supplies
$85.80-$0.68 (-0.79%)
Insider Score
––Not scored
SOLV Insider Score
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
SOLV Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 |
| Revenue | $1.95 B | $2.21 B | $2.01 B | $2.00 B | $2.10 B |
| Revenue Growth (YoY) | -7.01 % | — | — | — | — |
| Cost of Revenue | $887.00 M | $923.00 M | $911.00 M | $971.00 M | $961.00 M |
| Gross Profit | $1.06 B | $1.29 B | $1.09 B | $1.03 B | $1.14 B |
| SG&A Expense | $813.00 M | $927.00 M | $827.00 M | $759.00 M | $780.00 M |
| R&D Expense | $181.00 M | $178.00 M | $189.00 M | $175.00 M | $183.00 M |
| Operating Expenses | $994.00 M | $1.10 B | $1.02 B | $934.00 M | $963.00 M |
| Operating Income | $68.00 M | $181.00 M | $79.00 M | $93.00 M | $172.00 M |
| Pretax Income | -$11.00 M | $108.00 M | $16.00 M | $58.00 M | $1.51 B |
| Tax Provision | $1.00 M | $15.00 M | $3.00 M | -$5.00 M | $248.00 M |
| Net Income | -$12.00 M | $92.00 M | $13.00 M | $63.00 M | $1.27 B |
| EPS (Basic) | -$0.07 | $0.53 | $0.07 | $0.36 | $7.26 |
| EPS (Diluted) | -$0.07 | $0.53 | $0.07 | $0.36 | $7.22 |
| Shares Outstanding | 170.80 M | 172.70 M | 174.20 M | 174.40 M | 174.30 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
